These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8674054)

  • 1. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
    Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE
    Cancer Res; 1996 Jul; 56(13):2998-3003. PubMed ID: 8674054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
    Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C
    Oncogene; 2000 Feb; 19(8):1020-7. PubMed ID: 10713685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
    Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T; Korsmeyer SJ; Green JE
    EMBO J; 1999 May; 18(10):2692-701. PubMed ID: 10329616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice.
    Maroulakou IG; Shibata MA; Jorcyk CL; Chen XX; Green JE
    Mol Carcinog; 1997 Oct; 20(2):168-74. PubMed ID: 9364206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.
    Maroulakou IG; Anver M; Garrett L; Green JE
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11236-40. PubMed ID: 7972041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
    Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.
    Maroulakou IG; Shibata MA; Anver M; Jorcyk CL; Liu Ml; Roche N; Roberts AB; Tsarfaty I; Reseau J; Ward J; Green JE
    Oncogene; 1999 Sep; 18(39):5435-47. PubMed ID: 10498897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of interleukin-1beta converting enzyme (ICE)-induced apoptosis by SV40 large T antigen.
    Jung YK; Yuan J
    Oncogene; 1997 Mar; 14(10):1207-14. PubMed ID: 9121770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways.
    Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
    Cell Growth Differ; 1996 Jan; 7(1):13-20. PubMed ID: 8788029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.
    Shibata MA; Jorcyk CL; Devor DE; Yoshidome K; Rulong S; Resau J; Roche N; Roberts AB; Ward JM; Green JE
    Carcinogenesis; 1998 Jan; 19(1):195-205. PubMed ID: 9472712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
    Hoenerhoff MJ; Shibata MA; Bode A; Green JE
    Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
    Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
    Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
    Moore M; Teresky AK; Levine AJ; Seiberg M
    J Virol; 1992 Feb; 66(2):641-9. PubMed ID: 1370552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
    Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
    Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen.
    Conzen SD; Snay CA; Cole CN
    J Virol; 1997 Jun; 71(6):4536-43. PubMed ID: 9151847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, p21(WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells.
    Hsieh JK; Kletsas D; Clunn G; Hughes AD; Schachter M; Demoliou-Mason C
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):636-44. PubMed ID: 10712385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.